Form 8-K Kymera Therapeutics, For: Jun 25

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/23/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. BABA
7. AVGO
8. SPCX
9. BJ
10. NTES

Go back to Form 8-K Kymera Therapeutics, For: Jun 25

Kymera Therapeutics (KYMR) PT Lowered to $70 at Brookline Capital Markets

June 25, 2025 4:05 PM EDT

Brookline Capital Markets analyst Leah Rush Cann lowered the price target on Kymera Therapeutics (NASDAQ: KYMR) to $70.00 (from $97.00) while maintaining a Buy rating.

The analyst comments "Conclusions Our estimated revenue for 2025 2027 is being reduced resulting from timing of collaboration revenue from Sanofi. We have... More

Kymera Therapeutics (KYMR) PT Lowered to $64 at Jefferies

June 25, 2025 12:43 PM EDT

Jefferies analyst Kelly Shi lowered the price target on Kymera Therapeutics (NASDAQ: KYMR) to $64.00 (from $66.00) while maintaining a Buy rating.

The analyst comments "KYMR announced two updates on parternship: 1) SNY will not advance Ph2 IRAK4 degrader KT-474 in AD/HS and will... More

Stifel says buy Kymera Therapeutics (KYMR) on today's weakness

June 25, 2025 10:32 AM EDT

Stifel analyst Alex Thompson reiterated a Buy rating and $68.00 price target on Kymera Therapeutics (NASDAQ: KYMR), saying they would buy on today's weaknesses related to the updated on the Sanofi IRAK4 collaboration. Shares of KYMR are down 3.7% currently.

The analyst commented, "We are reiterating our Buy Rating on... More